CN104337822A - Compound tablets containing mebendazole and dipterex and used for deworming on pets, and preparation method thereof - Google Patents

Compound tablets containing mebendazole and dipterex and used for deworming on pets, and preparation method thereof Download PDF

Info

Publication number
CN104337822A
CN104337822A CN201310315888.3A CN201310315888A CN104337822A CN 104337822 A CN104337822 A CN 104337822A CN 201310315888 A CN201310315888 A CN 201310315888A CN 104337822 A CN104337822 A CN 104337822A
Authority
CN
China
Prior art keywords
mebendazole
metrifonate
agent
tablet
tablet containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310315888.3A
Other languages
Chinese (zh)
Inventor
栾明娜
郝智慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QINGDAO CONLINENT ANIMAL PHARMACEUTICAL CO Ltd
Original Assignee
QINGDAO CONLINENT ANIMAL PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINGDAO CONLINENT ANIMAL PHARMACEUTICAL CO Ltd filed Critical QINGDAO CONLINENT ANIMAL PHARMACEUTICAL CO Ltd
Priority to CN201310315888.3A priority Critical patent/CN104337822A/en
Publication of CN104337822A publication Critical patent/CN104337822A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention belongs to the technical field of veterinary deworming drugs and preparation methods thereof, particularly to tablets containing mebendazole and dipterex and used for treating and deworming on pets, and a preparation method thereof. The formulation comprises (a) bulk drugs mebendazole and dipterex, (b) a binder, (c) a wetting agent, (d) a disintegrating agent, (e) a filler, and (f) a sweetening agent. According to the present invention, the tablets containing mebendazole and dipterex are prepared by adopting the wet method, are the white tablets, have characteristics of good stability and good palatability, and can be used as the veterinary oral formulation.

Description

A kind of pet parasite expelling is with containing mebendazole+metrifonate compound tablet and preparation method thereof
Technical field
The invention belongs to analgesia for animals and preparation method technical field, be specifically related to the preparation method of a kind of mebendazole+metrifonate tablet.
Technical background
Mebendazole is a wide spectrum anthelmintic, in body or in vitro tests all prove directly to suppress nematicide to the absorption of glucose, cause glycogen depletion, make it survive, there is the effect killed larva significantly, suppress ovulation development, but do not affect blood in human body in sugar level.Can be used for the intestinal parasitical diseases such as control ancylostome, ascarid, pinworm, whipworm, excrement class loop line worm.
Mebendazole+metrifonate is utilized wet preparation method by prominent features of the present invention exactly, is prepared into oral tablet for animals.The mebendazole prepared by this method+metrifonate tablet stability is good, good palatability, the assimilation effect that tool is good, for China's veterinary clinic utilizes mebendazole+metrifonate to provide a kind of new preparation better.
Summary of the invention
The object of the invention is to develop a kind of mebendazole+metrifonate oral tablet, heighten the effect of a treatment, improve stability and the palatability of medicine, tool long-acting.
The present invention, for achieving the above object, provides a kind of water tablet containing mebendazole+metrifonate, it is characterized in that preparation specifically consists of:
(a) mebendazole+metrifonate crude drug 5-20% (W/W);
(b) binding agent 10-30% (W/W);
(c) wetting agent 5-20% (W/W);
(d) disintegrating agent 20-50% (W/W);
(e) filler 20-30% (W/W);
(f) sweeting agent 2-3% (W/W);
Described a kind of tablet containing mebendazole+metrifonate, it is characterized in that disintegrating agent be selected from replace hydroxypropyl cellulose, carboxymethyl cellulose, carboxymethyl starch sodium, PVPP, cCMC-Na, cross-linked carboxymethyl cellulose are received, cross linked polyvinyl pyrrolidone, microcrystalline Cellulose one or more;
The tablet of described a kind of mebendazole+metrifonate, it is characterized in that described filler be selected from lactose, amylum pregelatinisatum, dextrin, microcrystalline Cellulose one or more.
Described a kind of tablet containing mebendazole+metrifonate, it is characterized in that described binding agent be selected from polyvidone (PVP), HPMC, PVP, methylcellulose, sodium carboxymethyl cellulose one or more.
Described a kind of tablet containing mebendazole+metrifonate, it is characterized in that described lubricant be selected from magnesium stearate, micropowder silica gel, talcous one or more.
Described a kind of tablet containing mebendazole+metrifonate, is characterized in that one or more that described sweeting agent is selected from aspartame, stevioside, protein sugar.
Described a kind of tablet containing mebendazole+metrifonate, when it is characterized in that granulating, the granularity of granule should control at 30 orders once.
Described a kind of tablet containing mebendazole+metrifonate, is characterized in that preparation method is as follows:
Measure all stock and adjuncts according to prescription, cross 30-120 mesh sieve; Wherein disintegrating agent and filler respectively in add and Extra Section, the ratio 1-4:1 of Nei Jia and Extra Section, weight ratio; Inside add and weigh respectively with Extra Section, and carry out labelling; By mebendazole+metrifonate raw material and all in add adjuvant and put mix homogeneously in mixer altogether; Add binding agent, continue mixing, make soft material, 30 mesh sieves are granulated; By granule after 50 ° of C-55 ° of C are dried, 30 mesh sieve granulate.
Detailed description of the invention
Be explained the present invention with example below, but example does not limit the scope of the invention, scope of the present invention and core content are determined according to claims.
Example: 10% mebendazole+metrifonate water tablet
[prescription] mebendazole+metrifonate 5+10% (W/W)
Microcrystalline Cellulose 20% (W/W)
PVP 15% (W/W)
Lactose 30% (W/W)
Aluminium stearate 10% (W/W)
Aspartame 15% (W/W)
[preparation]
Get prescription and measure mebendazole+metrifonate and above-mentioned various adjuvant is prepared according to aforementioned preparation process, be i.e. obtained mebendazole+metrifonate water tablet.

Claims (5)

1., containing a tablet for mebendazole+metrifonate, it is characterized in that preparation specifically consists of:
(a) mebendazole+metrifonate crude drug 5-20% (W/W);
(b) binding agent 10-30% (W/W);
(c) wetting agent 5-20% (W/W);
(d) disintegrating agent 20-50% (W/W);
(e) filler 20-30% (W/W);
(f) sweeting agent 2-3% (W/W);
By a kind of tablet containing mebendazole+metrifonate according to claim 1, it is characterized in that disintegrating agent be selected from replace hydroxypropyl cellulose, carboxymethyl cellulose, carboxymethyl starch sodium, PVPP, cCMC-Na, cross-linked carboxymethyl cellulose are received, cross linked polyvinyl pyrrolidone, microcrystalline Cellulose one or more;
By the tablet of a kind of mebendazole+metrifonate according to claim 1, it is characterized in that described filler be selected from lactose, amylum pregelatinisatum, dextrin, microcrystalline Cellulose one or more.
2. by a kind of tablet containing mebendazole+metrifonate according to claim 1, it is characterized in that described binding agent be selected from polyvidone (PVP), HPMC, PVP, methylcellulose, sodium carboxymethyl cellulose one or more.
3. by a kind of tablet containing mebendazole+metrifonate according to claim 1, it is characterized in that described lubricant be selected from magnesium stearate, micropowder silica gel, talcous one or more.
4., by a kind of tablet containing mebendazole+metrifonate according to claim 1, it is characterized in that one or more that described sweeting agent is selected from aspartame, stevioside, protein sugar.
5., by a kind of tablet containing mebendazole+metrifonate according to claim 1, when it is characterized in that granulating, the granularity of granule should control at 30 orders once.
CN201310315888.3A 2013-07-25 2013-07-25 Compound tablets containing mebendazole and dipterex and used for deworming on pets, and preparation method thereof Pending CN104337822A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310315888.3A CN104337822A (en) 2013-07-25 2013-07-25 Compound tablets containing mebendazole and dipterex and used for deworming on pets, and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310315888.3A CN104337822A (en) 2013-07-25 2013-07-25 Compound tablets containing mebendazole and dipterex and used for deworming on pets, and preparation method thereof

Publications (1)

Publication Number Publication Date
CN104337822A true CN104337822A (en) 2015-02-11

Family

ID=52494815

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310315888.3A Pending CN104337822A (en) 2013-07-25 2013-07-25 Compound tablets containing mebendazole and dipterex and used for deworming on pets, and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104337822A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106420733A (en) * 2016-10-17 2017-02-22 朱隆娅 Mebendazole-levamisole tablet and preparation method thereof
CN106665645A (en) * 2016-12-22 2017-05-17 德州京新药业有限公司 Refined trichlorfon composition and preparation method and application thereof
CN111494327A (en) * 2020-06-23 2020-08-07 瑞阳制药有限公司 Preparation method of mebendazole chewable tablet

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106420733A (en) * 2016-10-17 2017-02-22 朱隆娅 Mebendazole-levamisole tablet and preparation method thereof
CN106665645A (en) * 2016-12-22 2017-05-17 德州京新药业有限公司 Refined trichlorfon composition and preparation method and application thereof
CN106665645B (en) * 2016-12-22 2019-08-27 德州京信药业有限公司 A kind of refining dipterex composition and the preparation method and application thereof
CN111494327A (en) * 2020-06-23 2020-08-07 瑞阳制药有限公司 Preparation method of mebendazole chewable tablet
CN111494327B (en) * 2020-06-23 2023-09-05 瑞阳制药股份有限公司 Preparation method of mebendazole chewable tablet

Similar Documents

Publication Publication Date Title
JP6220485B2 (en) Dispersion preparation containing colloidal bisma pectin and method for producing the same
CN104337822A (en) Compound tablets containing mebendazole and dipterex and used for deworming on pets, and preparation method thereof
CN103494781B (en) Montelukast sodium chewing tablet prescription and preparation process thereof
CN102935084A (en) Compound ivermectin sustained release tablet and preparation method thereof
CN108721243A (en) Gram azoles is for Buddhist nun's pharmaceutical composition and preparation method thereof
CN103751201A (en) Anti-parasitic orally disintegrating tablet for dogs and cats and preparation method thereof
CN103142494A (en) Ornidazole oral preparation and preparation method thereof
CN103385876A (en) Frovatriptan medicine composition and preparation method thereof
CN101011362A (en) Dispersible tablet of pidotimod and its preparing process and use
CN105213337A (en) Albendazole dispersible tablet for animals and preparation method thereof
CN104116718A (en) Itopride hydrochloride oral preparation
CN104983711A (en) Vilazodone hydrochloride capsule composition
CN104274415A (en) Atipamezole hydrochloride-containing calming and pain easing tablet for pets, and preparation method thereof
CN101642442B (en) Tablets for preventing and curing osteoarthritis and preparation method thereof
CN104337776A (en) Tablets containing diclofenac sodium and having analgesic effect on pets, and preparation method thereof
CN104338113A (en) Amfomycin calcium + hydrocortisone + kanamycin sulfate compound tablet for infection prevention of pets, and its preparation method
CN103070829A (en) Medicine composition including pramipexole and active ingredients of medicinal salt and preparation method thereof
CN103006597A (en) Voglibose tablet and preparation method thereof
CN103127019B (en) Florfenicol dispersible tablet as well as preparation method and application thereof
CN104721157A (en) Epsiprantel-containing pet tablet and preparation method thereof
CN104337777A (en) Tablets containing ketoprofen and having analgesic effect on pets, and preparation method thereof
CN102872013A (en) Anti-parasitic disease compound Triclabendazole granule for flocks and herds and preparation method for anti-parasitic disease compound Triclabendazole granule
CN103877092A (en) Compound niclosamide chewing tablet used for dogs and cats
CN103142527A (en) Entecavir potassium tablet and preparation method thereof
CN104721216A (en) Decoquinate and lincomycin hydrochloride-containing pet insect repellent tablet and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150211